Development of asolectin-based liposomal formulation for controlled and targeted delivery of erlotinib as a model drug for EGFR monotherapySnehal Pardeshi, Manish K. Chourasia, Amrendra Tiwari et al.|Journal of Liposome Research|2022Cited by 5